These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23185801)

  • 21. Locally advanced and metastatic breast cancer in a tertiary hospital.
    Tan EY; Wong HB; Ang BK; Chan MY
    Ann Acad Med Singap; 2005 Nov; 34(10):595-601. PubMed ID: 16382243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast infiltrating ductal carcinoma: analysis of hormone, HER-2 receptors and Ki-67 proliferation marker.
    Mustać E; Zamolo G; Petković M; Dordević G; Radić J; Grgurević E; Batinac T
    Coll Antropol; 2008 Sep; 32(3):741-6. PubMed ID: 18982746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seasonal trends in the self-detection of breast cancer: indications from the Cancer and Steroid Hormone (CASH) study.
    Ross JA; Severson RK; Davis S; Stanford JL; Potter JD
    Breast Cancer Res Treat; 1997 Jan; 42(2):187-92. PubMed ID: 9138608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Male breast cancer in the veterans affairs population: a comparative analysis.
    Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
    Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation therapy: a major factor in the five-year survival analysis of women with breast cancer in Lagos, Nigeria.
    Makanjuola SB; Popoola AO; Oludara MA
    Radiother Oncol; 2014 May; 111(2):321-6. PubMed ID: 24746579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology, stage at diagnosis, and tumor biology of breast carcinoma in multiracial and multiethnic populations.
    Hunter CP
    Cancer; 2000 Mar; 88(5 Suppl):1193-202. PubMed ID: 10705354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing patterns in the clinical characteristics of Korean patients with breast cancer during the last 15 years.
    Son BH; Kwak BS; Kim JK; Kim HJ; Hong SJ; Lee JS; Hwang UK; Yoon HS; Ahn SH
    Arch Surg; 2006 Feb; 141(2):155-60. PubMed ID: 16490892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer.
    Collins LC; Marotti JD; Gelber S; Cole K; Ruddy K; Kereakoglow S; Brachtel EF; Schapira L; Come SE; Winer EP; Partridge AH
    Breast Cancer Res Treat; 2012 Feb; 131(3):1061-6. PubMed ID: 22080245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective analysis of neoadjuvant chemotherapy for breast cancer in Turkish patients.
    Duman BB; Afşar ÇU; Günaldi M; Sahin B; Kara IO; Erkisi M; Erçolak V
    Asian Pac J Cancer Prev; 2012; 13(8):4119-23. PubMed ID: 23098527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database.
    Anderson WF; Chu KC; Chatterjee N; Brawley O; Brinton LA
    J Clin Oncol; 2001 Jan; 19(1):18-27. PubMed ID: 11134191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
    Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
    Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel.
    Dede DS; Gumuskaya B; Guler G; Onat D; Altundag K; Ozisik Y
    J BUON; 2013; 18(1):57-63. PubMed ID: 23613389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of estrogen and progesterone receptors in human ductal invasive breast carcinoma not otherwise specified: is there any difference between premenopausal and postmenopausal women?
    Petricević J; Petković M; Jonjić N
    Acta Clin Croat; 2011 Jun; 50(2):169-75. PubMed ID: 22263379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.
    Marshall SF; Bernstein L; Anton-Culver H; Deapen D; Horn-Ross PL; Mohrenweiser H; Peel D; Pinder R; Purdie DM; Reynolds P; Stram D; West D; Wright WE; Ziogas A; Ross RK
    J Natl Cancer Inst; 2005 Jun; 97(11):805-12. PubMed ID: 15928301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
    Reiner AS; Lynch CF; Sisti JS; John EM; Brooks JD; Bernstein L; Knight JA; Hsu L; Concannon P; Mellemkjær L; Tischkowitz M; Haile RW; Shen R; Malone KE; Woods M; Liang X; Morrow M; Bernstein JL;
    Breast Cancer Res; 2017 Jul; 19(1):83. PubMed ID: 28724391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High incidence of triple-negative tumors in sub-saharan Africa: a prospective study of breast cancer characteristics and risk factors in Malian women seen in a Bamako university hospital.
    Ly M; Antoine M; Dembélé AK; Levy P; Rodenas A; Touré BA; Badiaga Y; Dembélé BK; Bagayogo DC; Diallo YL; Koné AA; Callard P; Bernaudin JF; Diallo DA
    Oncology; 2012; 83(5):257-63. PubMed ID: 22964749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer.
    Fagherazzi G; Chabbert-Buffet N; Fabre A; Guillas G; Boutron-Ruault MC; Mesrine S; Clavel-Chapelon F
    Int J Obes (Lond); 2012 Mar; 36(3):431-9. PubMed ID: 21427693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors.
    Guo C; Sung H; Zheng S; Guida J; Li E; Li J; Hu N; Deng J; Figueroa JD; Sherman ME; Gierach GL; Lu N; Yang XR
    Breast Cancer Res; 2017 May; 19(1):61. PubMed ID: 28545469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer in young women from a low risk population in Nepal.
    Thapa B; Singh Y; Sayami P; Shrestha UK; Sapkota R; Sayami G
    Asian Pac J Cancer Prev; 2013; 14(9):5095-9. PubMed ID: 24175782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrence dynamics of breast cancer according to baseline body mass index.
    Biganzoli E; Desmedt C; Fornili M; de Azambuja E; Cornez N; Ries F; Closon-Dejardin MT; Kerger J; Focan C; Di Leo A; Nogaret JM; Sotiriou C; Piccart M; Demicheli R
    Eur J Cancer; 2017 Dec; 87():10-20. PubMed ID: 29096156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.